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Lipopolysaccharide-induced NF-κB 
nuclear translocation is primarily 
dependent on MyD88, but TNFα 
expression requires TRIF and 
MyD88
Jiro Sakai  1, Eugenia Cammarota2, John A. Wright  1, Pietro Cicuta2, Rachel A. Gottschalk3, 
Ning Li3, Iain D. C. Fraser3 & Clare E. Bryant1
TLR4 signalling through the MyD88 and TRIF-dependent pathways initiates translocation of the 
transcription factor NF-κB into the nucleus. In cell population studies using mathematical modeling and 
functional analyses, Cheng et al. suggested that LPS-driven activation of MyD88, in the absence of TRIF, 
impairs NF-κB translocation. We tested the model proposed by Cheng et al. using real-time single cell 
analysis in macrophages expressing EGFP-tagged p65 and a TNFα promoter-driven mCherry. Following 
LPS stimulation, cells lacking TRIF show a pattern of NF-κB dynamics that is unaltered from wild-type 
cells, but activation of the TNFα promoter is impaired. In macrophages lacking MyD88, there is minimal 
NF-κB translocation to the nucleus in response to LPS stimulation, and there is no activation of the 
TNFα promoter. These findings confirm that signalling through MyD88 is the primary driver for LPS-
dependent NF-κB translocation to the nucleus. The pattern of NF-κB dynamics in TRIF-deficient cells 
does not, however, directly reflect the kinetics of TNFα promoter activation, supporting the concept 
that TRIF-dependent signalling plays an important role in the transcription of this cytokine.
Pattern Recognition Receptor (PRR) detection of pathogens activates innate immune response in cells such as 
macrophages to control infections1–3. The PRR toll-like receptor 4 (TLR4) and its associated co-receptor mye-
loid differentiation factor 2 (MD-2) sense the Gram-negative bacterial outer membrane component lipopoly-
saccharide (LPS)1, 4–7. Following association with LPS, TLR4 is activated at the cell surface and recruits myeloid 
differentiation primary response gene 88 (MyD88) to its cytosolic Toll/IL-1R (TIR) domain via the adaptor 
protein MyD88 adaptor-like (Mal)8–11. TLR4 subsequently undergoes endocytosis in a CD14-dependent man-
ner12, followed by recruitment of a second signalling adaptor protein TIR domain-containing adaptor-inducing 
interferon-beta (TRIF) via the TRIF-related adaptor molecule (TRAM)13–16. TLR4 signalling is transduced 
sequentially through the MyD88-dependent pathway from the cell membrane and the TRIF-dependent pathway 
from the endosome14, 16. There is a differential contribution of each pathway to inflammatory gene expression17, 
but how MyD88- and TRIF-dependent signalling impact on the dynamics of NF-κB translocation is unknown.
TLR4 signalling initiates translocation of the pro-inflammatory transcription factor nuclear factor 
kappa-light-chain enhancer of activated B cells (NF-κB) into the nucleus from the cytoplasm to induce gene 
transcription18–20. NF-κB in the nucleus is inactivated and exported out of the nucleus by the newly synthesized 
protein inhibitory κB (IκB)21, 22. The dynamics of NF-κB translocation in and out of the nucleus are thought to 
contribute to the pattern of inflammatory gene expression22, 23.
A recent study, coupling mathematical modeling to population-level functional analysis of MyD88-deficient 
and TRIF-deficient cells, suggested that LPS-driven activation of MyD88 in the absence of TRIF would alter 
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NF-κB dynamics24. Using the prediction from their mathematical model, the authors propose that the variability 
of NF-κB dynamics in macrophages depends upon variability in TRIF signalling which determines the kinetics 
of tumor necrosis factor α (TNFα) production24. Single cell studies, however, have demonstrated that data from 
population-level experiments using bulk assays do not necessarily reflect events in individual cells because the 
heterogeneity of each individual cellular response is masked22, 23, 25–29.
Here, we studied the responses of wild-type, MyD88-deficient or TRIF-deficient single macrophages to 
LPS. Our work shows that, in contrast to the predictive model24, the pattern of NF-κB dynamics is unaltered 
in TRIF-deficient macrophages, but is delayed with an altered pattern in MyD88-deficient cells. Activation of a 
TNFα promoter was simultaneously monitored to assess the correlation between the pattern of NF-κB dynamics 
and TNFα expression. Unlike wild-type cells, TRIF-deficient macrophages show impaired activation of the TNFα 
promoter following LPS stimulation, despite having comparable NF-κB dynamics.
Results
Live cell imaging demonstrates that NF-κB oscillates in response to LPS in the absence of 
TRIF. We set out to test the predictions of the mathematical model suggesting that NF-κB dynamics and 
TNFα production are impaired in LPS-dependent signalling in the absence of TRIF24, 30. We monitored NF-κB 
nuclear translocation and TNFα promoter activation in immortalized bone-marrow derived macrophage cell 
lines (iBMDM) from wild-type (WT), TRIF−/− (TKO), MyD88−/− (MKO), and TRIF−/−MyD88−/− (DKO) 
mice by live cell confocal microscopy following LPS stimulation (Fig. 1a). These four lines of iBMDM stably 
express p65 fused with enhanced green fluorescent protein (EGFP) and generated mCherry driven from a TNFα 
Figure 1. The different roles of MyD88- and TRIF-dependent pathways in LPS-induced NF-κB nuclear 
translocation and TNFα promoter activation. (a) Live cell imaging of EGFP-tagged NF-κB nuclear 
translocation (upper panels) and TNFα promoter-driven mCherry fluorescence (lower panels) in wild-type 
(WT), TRIF−/− (TKO), MyD88−/−(MKO), and TRIF−/−/MyD88−/− (DKO) in response to 500 ng/mL LPS. 
The scale bar indicates 50 μm. (b) A schematic diagram of TLR4 signaling to NF-κB and TNFα promoter 
activation in the reporter cells. TLR4 signal is mediated by MyD88- and TRIF-dependent pathways to activate 
NF-κB. The activated NF-κB translocates into the nucleus where it associates with the TNFα promoter, which 
induces mCherry gene transcription. (c) Time course of the ratio of NF-κB in the nucleus (Nuc) to those in 
the cytoplasm (Cyt) (left column), and the ratio of mCherry fluorescence intensity inside a cell (Cell) to those 
outside (background (BG)) (right column) in the reporter cells. Each figure shows four representatives of 
approximately 50 cells from four independent experiments. Individual cells are shown by coloured lines.
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promoter (Fig. 1b)31. The authenticity of the cell lines was verified by genotyping assays (Supplementary Fig. S1). 
NF-κB nuclear translocation following LPS stimulation was observed in all of the WT cells monitored in four 
independent experiments (Fig. 1a upper; Supplementary Movie 1). Single cell analysis (Supplementary Fig. S2) 
demonstrated that the oscillatory pattern of NF-κB dynamics consisted of a large initial peak followed by smaller 
secondary peaks in response to continuous LPS stimulation (Fig. 1c). TNFα promoter-driven mCherry flu-
orescence was simultaneously monitored (Fig. 1a lower; Supplementary Movie 2). The intensity of mCherry 
fluorescence gradually increased after LPS stimulation (Fig. 1c). The mCherry fluorescence reached a peak at 
approximately 450 minutes post-LPS stimulation and then decreased in most WT cells.
Next, we monitored NF-κB dynamics in TKO cells stimulated by LPS. Cheng et al. proposed that NF-κB is 
only activated by MyD88 so that in TKO cells there would be no second-phase NF-κB activity24. We found, how-
ever, that NF-κB oscillated in TKO in response to LPS (Fig. 1a upper; Supplementary Movie 4) with a pattern that 
appeared to be very similar to that seen in WT cells (Fig. 1c). The mCherry expression driven from the TNFα 
promoter did not increase in TKO following LPS stimulation, in contrast to WT cells (Fig. 1a lower and 1c right; 
Supplementary Movie 5). In LPS-stimulated MyD88−/− cells, NF-κB translocation was delayed compared to WT 
cells and mCherry intensity did not increase (Fig. 1a,c; Supplementary Movie 7; Supplementary Movie 8). No 
NF-κB translocation or increase in mCherry intensity were observed in LPS-stimulated DKO (Fig. 1a upper; 
Supplementary Movie 10; Supplementary Movie 11). The slight fluctuations of NF-κB translocation in DKO 
were similar in the presence or absence of LPS stimulation (Fig. 1c), suggesting that LPS stimulation did not elicit 
NF-κB translocation in DKO cells.
The timing of NF-κB nuclear translocation is the same in the presence or absence of TRIF in 
response to LPS. We quantified the timing of NF-κB translocation in and out of the nucleus from single 
cell analysis of WT (n = 67), TKO (n = 50), and MKO (n = 48) (Fig. 2; Supplementary Table S1). Both WT and 
TKO initiated NF-κB nuclear translocation within 10 minutes after LPS stimulation, and there was no significant 
Figure 2. Timings of LPS-induced NF-κB nuclear translocation in TRIF-deficient macrophages are similar to 
those in wild-type macrophages. Population distributions of initiation timing (a), peak timing (b), and duration 
between initiation and peak timing (c) of the first peak in NF-κB nuclear translocation dynamics in the iBMDM 
reporter. Each dot shows a single cell from four independent experiments for each cell line. The bars show 
mean value ± s.d. (d) Peak timings of the second and third peaks in NF-κB nuclear translocation dynamics. 
***P < 0.0001, **P < 0.01, *P < 0.05, one-way ANOVA with Kruskal-Wallis test.
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difference in initiation timing between the two cell types (p = 0.1476) (Fig. 2a; Supplementary Table S1). Initiation 
of the first peak in MKO was very heterogeneous with the mean initiation timing significantly delayed com-
pared to WT and TKO (p < 0.0001) (Fig. 2a; Supplementary Table S1). The time taken to achieve the maxi-
mum fluorescent intensity for the first peak of NF-κB nuclear translocation were similar for WT and TKO cells 
(p > 0.9999) (Fig. 2b; Supplementary Table S1), but in the MKO it was significantly delayed (p < 0.0001) (Fig. 2b; 
Supplementary Table S1). To assess NF-κB nuclear occupancy during the first peak, we assumed a symmetrical 
peak because we did not observe a sustained nuclear occupancy after the highest point of the first peak. We thus 
calculated NF-κB nuclear duration time by subtracting the peak initiation time from the time the fluorescence 
achieving the maximum nuclear intensity (Fig. 2c; Supplementary Table S1). There was no significant difference 
in nuclear duration time between WT and TKO cells stimulated with LPS (p > 0.9999), while NF-κB occupied in 
the nucleus for a significantly longer period of time for MKO cells (p < 0.0001) (Fig. 2c; Supplementary Table S1).
Next, we quantified the timings of the secondary peaks of NF-κB translocation. We counted the peaks above 
noise level to be NF-κB nuclear translocations and confirmed that these peaks were genuine NF-κB nuclear 
translocations by inspecting the corresponding fluorescent live cell movies. A second peak was observed in 96% 
of WT and 94% of TKO with a third peak present in 84% of WT and 84% of TKO. The second and third peaks 
in TKO were slightly delayed compared to those in WT (Fig. 2d; Supplementary Table S1). The mean interval 
from the first peak to the second peak was longer in TKO than in WT (p = 0.0014), whereas there was no signif-
icant difference in the mean interval from the second peak to the third peak between WT and TKO (p = 0.27) 
(Supplementary Table S2). 70% of MKO cells showed a first peak of NF-κB translocation, and the second and 
third peaks were detected in 60% and 17% of cells with a first peak, respectively. The timings of both the second 
and third peaks in MKO were significantly later than those seen in LPS-stimulated WT and TKO (p < 0.0001) 
(Fig. 2d; Supplementary Table S1). The standard deviation of the second peak was greater than that of the first 
peak, and the standard deviation of the third peak was greater still in all the three strains (Supplementary 
Table S1), suggesting that the primary NF-κB peak is relatively synchronized between LPS-stimulated cells, but 
subsequent NF-κB translocation is more heterogeneous32.
TRIF deficiency does not affect the magnitude of NF-κB nuclear translocation in macrophages 
in response to LPS. Robust NF-κB oscillation upon TNFα stimulation has been observed in several types 
of cells such as SK-N-AS cells22 and fibroblasts27, 33, but there is a progressively decreasing oscillation of NF-κB 
dynamics in the macrophage cell line RAW264.724, 31 and in our iBMDM cells in response to LPS. We compared 
the heights of the first, second, and third peaks of NF-κB translocation to assess if TLR4 adaptor proteins are 
important for dampening the oscillatory patterns of NF-κB translocation. There were no significant differences 
in the heights of the first and second peaks between WT and TKO (p > 0.9999), but these peaks in MKO were 
significantly lower than WT and TKO (p < 0.0001) (Fig. 3a,b; Supplementary Table S3). Unlike the first and 
second peaks, there was no significant difference in the height of the third peak between these three cell types 
(p > 0.9999) (Fig. 3b right; Supplementary Table S3). Next, we compared the reduction rate (damping) of the 
height from the first peak to the second peak, and from the second peak to the third peak. Damping in TKO 
were comparable to those in WT from the first peak to the second peak (Fig. 3c left; Supplementary Table S4) 
and also from the second peak to the third peak (Fig. 3c right; Supplementary Table S4). Thus, any damping 
mechanism of NF-κB translocation oscillation is intact in the absence of TRIF. In MKO, however, whereas the 
first peak was significantly lower compared to WT and TKO, there was no significant damping. This implies that 
the damping mechanism is likely to specifically target MyD88-dependent signalling, or it may be activated in a 
MyD88-dependent manner.
TRIF does not regulate the number of LPS-induced NF-κB oscillations, but is important for 
TNFα promoter activation. A correlation between the pattern of NF-κB dynamics and target gene expres-
sion has been suggested in a variety of cell types22, 27, 32, so we assessed the pattern of NF-κB oscillations in the 
various iBMDMs used in the study. The median number of peaks in WT cells was 3 peaks (range 1–5 peaks), in 
TKO was 4 peaks (range 1–7 peaks) whereas in MKO it was significantly less (median 2 peaks, range 1–3 peaks) 
(p < 0.0001) (Fig. 3d). This result shows that the pattern of LPS-induced NF-κB oscillations was not impaired 
by TRIF deficiency, but was clearly perturbed in the absence of MyD88. Next, we quantified TNFα promoter 
activation in response to LPS as the fold increase of mCherry fluorescence driven from the TNFα promoter. WT 
cells had a 2.1 ± 1.5 fold increase of mCherry fluorescence, whereas TKO showed only a 1.2 ± 0.4 fold increase 
(Fig. 3e; Supplementary Table S5). There was no increase in mCherry fluorescence in MKO or DKO in response 
to LPS stimulation. The impaired TNFα induction in TKO was also confirmed using flow cytometric analysis 
(Supplementary Fig. S3) since KDO2-Lipid A induces macrophage activation via the TLR4 signalling pathway in 
a similar manner to LPS34.
Discussion
Here we show that the adaptor protein TRIF does not regulate the pattern of NF-κB translocation into and out of 
the nucleus in bone marrow derived macrophages. NF-κB plays a key role in LPS-induced inflammatory cytokine 
production20, and thus several studies have sought to correlate the pattern of NF-κB nuclear translocation dynam-
ics with the kinetics of target gene expression22, 24, 27, 31. MyD88- and TRIF-dependent signalling are both impor-
tant for driving LPS-induced TNFα production via NF-κB activation16, 35–42. No assessment has yet been made at 
the single cell level to show how MyD88- and TRIF-dependent signalling might correlate the NF-κB dynamics 
with target gene expression.
Cell population analysis which assesses a normalized cellular response in a population at a specific time point 
does not give any information about heterogeneity in NF-κB dynamics (Supplementary Fig. S4)22, 23, 25–29. Our 
data shows that the initial nuclear translocation of NF-κB after LPS stimulation is well synchronized between cells 
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whereas the timing of secondary NF-κB translocations is very heterogeneous (Fig. 2; Supplementary Table S1). 
Other work investigating the dynamics of NF-κB translocation in a murine macrophage cell line used reporters 
stably expressed in RAW264.7 macrophages in response to LPS24, 31. We used RAW264.7 reporter cells to compare 
the signalling responses to, and validate the use of, the wild-type iBMDM reporter cells (Supplementary Fig. S5). 
No significant differences were seen in oscillatory patterns of NF-κB translocation in and out of the nucleus and 
TNFα promoter activation following LPS stimulation between the wild-type iBMDMs and RAW264.7 cells.
Mathematical modeling coupled to population cell analysis suggested that the patterns of LPS-induced NF-κB 
oscillation are regulated by TRIF signalling24. The model predicted that the absence of TRIF would not affect the 
primary peak of NF-κB translocation, but would suppress all secondary translocations of NF-κB in and out of the 
nucleus. Our work set out to test this model, but we found that the pattern of LPS-induced NF-κB oscillation in 
TRIF−/− cells is similar to that observed in wild-type cells. Our results are consistent with previous reports that 
LPS-induced NF-κB translocation is mainly dependent on MyD88, but with little involvement of TRIF8, 16, 18, 43. 
In the absence of either TRIF or MyD88, we see little or no TNFα promoter activation respectively (Fig. 3e) sug-
gesting that TNFα promoter activation is lost/reduced even when NF-κB oscillations are preserved. Hence our 
data suggests that some other feature of the system drives TNFα expression – either modification of NF-κB p65, 
that we cannot observe, or via some other distinct mechanism. For example, mitogen-activated protein kinases 
(MAPK) have an essential role in TLR4 ligand-induced TNFα production independent of NF-κB44. Rosadini et 
al. have shown that cytokine expression requires TRIF-dependent signalling to activate the MAPK-induced (acti-
vator protein 1) AP-145. It is possible that there is interplay between NF-κB and AP-1 to generate efficient gene 
transcription46, 47. Our findings suggest that NF-κB nuclear translocation is essential but insufficient to activate 
Figure 3. The magnitude of NF-κB nuclear translocation is not affected by the lack of TRIF-dependent 
signalling in response to LPS. The number of LPS-induced NF-κB oscillations does not decrease but TNFα 
promoter-driven mCherry expression is inhibited in TRIF-deficient macrophages in response to LPS. Each dot 
shows a single cell from four independent experiments for each cell line. The heights of the first peak (a), and 
the second and third peaks (b) of NF-κB translocation were determined by the value of the highest point in each 
peak of NF-κB translocation curve. (c) Damping rates indicate the decrease from the first peak to the second 
peak (1st → 2nd), and from the second peak to the third peak (2nd → 3rd). The bars show mean value ± s.d. 
***P < 0.0001, **P < 0.01, one-way ANOVA with Kruskal-Wallis test. (d) The number of peaks in NF-κB 
nuclear translocation dynamics. Peaks above noise level that was determined by NF-κB curve in unstimulated 
cells were counted. The bars show median with range. (e) The fold increase of mCherry fluorescence intensity 
in response to LPS. Each dot shows a single cell from four independent experiments for each cell line. The bars 
show mean value ± s.d. The dot line indicates an one-fold (no increase). ***P < 0.0001, *P < 0.05, one-way 
ANOVA with Kruskal-Wallis test.
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tnfα gene expression. Activation of the TNFα promoter is likely, therefore, to require the cooperation of tran-
scription factors distinctly activated by MyD88-dependent and TRIF-dependent signalling.
While NF-κB in TRIF-deficient macrophages was transported in and out of the nucleus in a similar pattern 
to that in wild-type cells, the 2nd and 3rd peaks in the NF-κB dynamics of TRIF-deficient cells were slightly but 
significantly delayed compared to those in wild-type cells (p = 0.0115 for the 2nd and 0.0161 for the 3rd peaks) 
(Fig. 2d). There have been few reports about the effects of delayed 2nd and 3rd peaks on gene expression. Timings 
of NF-κB nuclear translocation were shown to be out of phase with the cycle of IκBα replenishment48. We specu-
late that the delayed dynamics of NF-κB nuclear translocation can overlap with the peak of IκBα replenishment 
kinetics. This could result in faster interactions between NF-κB and IκBα in the nucleus, and thus NF-κB could 
be inactivated and shuttled out of the nucleus before it activates gene transcription.
We were not able to determine the source of the 2nd, 3rd and later phases of NF-κB activation in TRIF-deficient 
cells. Potentially there are different mechanisms that might explain the later peaks of NF-κB activation we see in 
LPS-stimulated TRIF-deficient cells. In TNFα- or LPS-stimulated primary mouse embryo fibroblasts (MEFs), 
autocrine/paracrine TNFα receptor signalling is important and it is possible that a similar ‘autocrine/paracrine’ 
mechanism explains MyD88/TRIF-independent signalling to activate the late phase of NF-κB translocation to 
and from the nucleus29, 49. LPS-stimulated wild-type MEFs show later initiation of NF-κB movement to and from 
the nucleus compared to iBMDMs, whereas TNFα-stimulated MEFs show rapid and oscillatory NF-κB nuclear 
translocation29. The difference in NF-κB response to LPS between iBMDMs and MEFs, however, may suggest that 
macrophages have different mechanisms that drive the late phase NF-κB activation in comparison to those used 
by MEFs, so autocrine/paracrine TNFα-dependent mechanism may not explain our data.
In summary, we propose that MyD88-dependent signalling plays a dominant role in LPS-induced NF-κB 
nuclear translocation, but with both MyD88 and TRIF-dependent signalling contributing to NF-κB-dependent 
tnfα gene transcription (Fig. 4). Comparison of our data with TNFα stimulation of fibroblasts shows some simi-
larities in the patterns of NF-κB oscillation. In TNFα stimulated fibroblasts there is an interval of approximately 
90 minutes between NF-κB translocation peaks22, 27, 32, 33 which is similar to what we observe in WT iBMDM 
(Supplementary Table S2). Considering the consistency of the periodic pattern in NF-κB dynamics between 
different types of cells in response to different stimuli, we speculate that the IκB-IKK feedback system may be 
mainly responsible for the pattern of NF-κB oscillatory dynamics regardless of the type of cell or the upstream 
Figure 4. A representative schematic of the proposed TRIF contribution to NF-κB-dependent TNFα promoter 
activation. LPS activates TLR4 at the cell surface resulting in MyD88 activation via Mal. LPS also promotes 
TLR4 endocytosis following association with CD14 in the presence of the LPS-binding protein (LBP). TLR4 in 
the endosome subsequently recruits TRIF via TRAM. TLR4 signalling is transduced sequentially through the 
MyD88-dependent pathway from the cell membrane and the TRIF-dependent pathway from the endosome. 
Signals through MyD88-dependent and TRIF-dependent pathways distinctly activate IκB kinase (IKK) via 
the TNF receptor associated factor 6 (TRAF6) and the kinase receptor interacting protein 1 (RIP1). Activated 
IKK causes phosphorylation and degradation of IκB followed by NF-κB translocation to the nucleus. In the 
nucleus, NF-κB activates several promoters. NF-κB requires the cooperation of TRIF-dependent signalling to 
activate the TNFα promoter. NF-κB also activates promoters of negative regulators including IκB and A20. 
IκB inactivates NF-κB and leads it to shuttle out of the nucleus. A20 suppresses IKK through inhibition of the 
upstream signalling.
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signalling33. Macrophages, however, exhibit a large first peak followed by smaller secondary peaks in NF-κB oscil-
lation (Fig. 1c)24, 31 in comparison to fibroblasts exhibiting sustained NF-κB oscillation22, 27, 32, 33. We speculate that 
macrophages may have an efficient negative feedback mechanism to suppress signalling upstream of the IκB-IKK 
system, in comparison to non immune cells, in order to prevent overproduction of cytokines and to protect the 
host from hyper-inflammatory responses. It is possible that some molecules upregulated by NF-κB could suppress 
IKK activation as a negative feedback loop. For example, A20 has been well studied for its negative regulatory 
role in IKK activation23, 27, 28, 50. A20, however, is unlikely to be the negative regulator here because it is not only 
expressed in macrophages but also in many other types of cells including fibroblasts51. Our single cell analysis 
underscores the importance of selecting the correct functional analyses to elucidate the correct general wiring of 
the network before developing an accurate mathematical models of signaling networks.
Materials and Methods
Cell culture. The iBMDM-derived reporter cell line cells and RAW264.7 cells which express enhanced green 
fluorescent protein (EGFP)-tagged p65 and TNFα promoter-driven mCherry were developed as described 
previously31. The cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma-Aldrich) sup-
plemented with 10% (v/v) heat-inactivated fetal calf serum (FCS; Thermo Scientific), 2 mM L-glutamine (Sigma-
Aldrich) and 20 mM HEPES (Sigma-Aldrich) at 37 °C, 5% CO2. Primary BMDM were isolated from tibiae and 
femurs of C57BL/6, MyD88-/-37or TRIF-/-16 mice and cultured in DMEM with 10%(v/v) FCS, 20% L929, 2 mM 
L-glutamine, and 100 U/mL penicillin and streptomycin at 37 °C, 5% CO2.
Live cell microscopy. The cells were plated on a 35-mm glass-bottom dish (Greiner Bio-One, #627860) 
at a concentration of 1.0 × 105 cells in phenol red-free DMEM (Sigma-Aldrich) supplemented with 10% (v/v) 
FCS, 2 mM L-glutamine and 20 mM HEPES, and allowed to settle for 8 hours prior to experiments. The dish was 
mounted on the stage of a confocal microscope (TCS SP5, Leica) and kept at 37 °C, 5% CO2 during the exper-
iment in a climate chamber. Live cell imaging was performed immediately after stimulating the cells with LPS 
(Enzo Life Sciences). Images were sequentially captured through a 40× oil-immersion objective (NA1.25) with 
2.0x zoom every 3 minutes for 15 hours. EGFP was excited by argon laser at 488 nm with 15% laser power and 
mCherry by He-Ne laser at 594 nm with 8% laser power. The emission signals from EGFP and mCherry were 
collected with 504–565 nm band pass and 604–656 nm band pass, respectively. We also recorded the transmit-
ted beam as a bright field image. The image dimension used was 512 × 512 pixels. Scan speed was 100 lines per 
second, and 3 line averaging was applied. The pinhole size was 1 A.U., and the thickness of the focal plane was 
0.96 μm. Acquired images were exported as 16-bit TIFF files for MATLAB-based automated analysis.
MATLAB-based automated single cell analysis. A custom-built MATLAB script was used to auto-
matically assess NF-κB nuclear translocation and TNFα promoter-driven mCherry expression (Supplementary 
Fig. S2; the code can be accessed at http://dx.doi.org/10.17863/CAM.6018). Segmentation to determine the area 
of a cell body was performed based on information from both the EGFP and bright field images. A nuclear region 
was determined as a circle with a diameter which was selected manually. The area of a cell body was determined 
from the bright field images. A cytosolic area was defined as the area remaining after subtracting the nuclear area 
from the area of a cell body. The EGFP intensity of all pixels in the nucleus and the cytoplasm was measured and 
then averaged for the nuclear value and the cytosolic value in each frame. The ratio of the nuclear value to the 
cytosolic value was calculated in each frame and then averaged by ten frames to make a NF-κB nuclear translo-
cation curve. The NF-κB noise level was determined from fluctuations in NF-κB dynamics seen in unstimulated 
cells. Peaks above noise level were considered to be ones induced by NF-κB nuclear translocation. The intensity 
of mCherry fluorescence was measured from the area of a cell body determined by bright field images and then 
averaged for the cell body. Background noise was measured from an area without a cell and then averaged. This 
automated analysis only works for a single cell which is not next to another cell for the entire duration of movie. 
This is because the image analysis system is unable to distinguish two adjacent cells as being different from a 
single cell. We therefore excluded any cell that touches another cell or that divides during the course of imaging 
from the data analysis.
Flow cytometric analysis for TNFα induction. Primary macrophages for this analysis were prepared 
from murine bone marrow. Briefly, mice were maintained in specific pathogen free condition and all procedures 
were approved by the NIAID Animal Care and Use Committee (National Institute of Health, Bethesda, MD). 
Bone marrow progenitors were differentiated into BMDM during a 6-day culture in complete DMEM supple-
mented with 30 ng/mL recombinant mouse M-CSF (R&D systems), added at days 0 and 3. BMDM were re-plated 
on day 6 into 48-well plates and stimulated on day 7 with Kdo2-Lipid A (KLA; Avanti Polar Lipids), with addition 
of Brefeldin A (BD Goldi Plug). Anti-mouse TNFα antibody, clone MP6-XT22 (BioLegend) was used. The data 
were collected with a BD LSRFortessa and analyzed in FlowJo software.
Genotyping. DNA was extracted from the iBMDM reporter cell lines using a DNeasy Blood & Tissue Kit 
(Qiagen), and amplified by PCR using primers: MyD88 forward (5′-AGCCTCTACACCCTTCTCTTCTCCACA
-3 ′) ,  MyD88 reverse (5 ′-AGACAGGCTGAGTGCAAACT TGTGCTG-3 ′) ,  MyD88 neomycin 
( 5 ′ - ATC G C C T TC TATC G C C T TC T TG AC G AG - 3 ′ ) ,  T R I F  for w ard  ( 5 ′ - C TG AC AC AC TG T 
GTACTTACTAGGTGC-3′), TRIF reverse (5′-CAAGATTGGACTTCACCTGGGTCCTTA-3′), and TRIF neo-
mycin (5′-CTAAAGCGCATGCTCCAGACTGCCTTG-3′). The resulting PCR products were analyzed by elec-
trophoresis in 1% agarose gel with SYBR® Safe DNA gel stain (Invitrogen) at 100 volts.
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Western blot analysis. Following stimulation with LPS (Enzo Life Sciences), Cells were washed with cold PBS, 
gently scraped, and resuspended in lysis buffer (1.0% NP-40, 150 mM sodium chloride, 50 mM Tris, pH8.0) con-
taining proteinase inhibitor cocktail (Sigma-Aldrich) and phosphatase inhibitor cocktail 2 and 3 (Sigma-Aldrich). 
Protein samples were mixed with laemmli sample buffer (Bio-Rad), resolved by 12% SDS-PAGE gel, and transferred 
to nitrocellulose membranes (Millipore). The membrane was probed by phospho-NF-κB p65 (Ser536) rabbit mono-
clonal antibody (Cell signaling, #3033; 1:1000 dilution), NF-κB p65 rabbit polyclonal antibody (Santa Cruz, #sc-372; 
1:1000 dilution), Phospho-IRF3 (Ser396) rabbit monoclonal antibody (Cell signaling, #4947; 1:1000 dilution), IRF3 
rabbit monoclonal antibody (Cell signaling, #4302; 1:1000 dilution), IκBα rabbit polyclonal antibody (Santa Cruz, 
#sc-371; 1:1000 dilution), and α-actin goat polyclonal antibody (Santa Cruz, #sc-1616; 1:1000 dilution).
Statistical analysis. All statistical analyses were performed using Prism 6.0 software (GraphPad Prism). 
One-way analysis of variance (ANOVA) with Kruskal-Wallis test was followed by Dunn’s multiple comparison 
test. P < 0.05 was considered as significant difference.
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